Does MAFLD really increase the severity of COVID-19?
Dig Liver Dis
.
2021 Feb;53(2):166-167.
doi: 10.1016/j.dld.2020.10.042.
Epub 2020 Nov 11.
Authors
Jonny Karunia Fajar
1
,
Bogi Pratomo Wibowo
2
,
Gheavita Chandra Dewi
3
,
Adi Putra Rahmadi
3
,
Meike Tiya Kusuma
4
Affiliations
1
Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia.
2
Division of Gastro-Entero-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang 65117, Indonesia.
3
Faculty of Medicine, Universitas Sebelas Maret, Surakarta 57126, Indonesia.
4
Faculty of Medicine, Universitas Brawijaya, Malang 65117, Indonesia.
PMID:
33208296
PMCID:
PMC7657031
DOI:
10.1016/j.dld.2020.10.042
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Fatty Liver*
Humans
Risk Factors
SARS-CoV-2